Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Francisco Beca
Affiliation
Stanford University School of Medicine
ORCID
Career Start Year
2008
Papers
35
H Index
18
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
33376197
Stromal <i>MED12</i> exon 2 mutations in complex fibroadenomas of the breast.
J Clin Pathol
2022
33674619
The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease.
NPJ Breast Cancer
2021
35465400
Molecular analysis of TCGA breast cancer histologic types.
Cell Genom
2021
32123305
Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.
Mod Pathol
2020
32043609
Whole-exome analysis of metaplastic breast carcinomas with extensive osseous differentiation.
Histopathology
2020
33083532
The genomic landscape of metastatic histologic special types of invasive breast cancer.
NPJ Breast Cancer
2020
30595538
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.
Dev Cell
2019
31239270
<i>EN1</i> Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain Metastasis.
Cancer Res
2019
31350292
Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
J Clin Pathol
2019
31361912
Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast.
Histopathology
2019
30861443
Predicting breast tumor proliferation from whole-slide images: The TUPAC16 challenge.
Med Image Anal
2019
31141801
Ancillary Tests in Breast Cytology: A Practical Guide.
Acta Cytol
2019
30276234
Androgen receptor expression in normal breast tissue and subsequent breast cancer risk.
NPJ Breast Cancer
2018
27940576
Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling.
Cancer Res
2017
28253895
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.
Breast Cancer Res
2017
29234806
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
JAMA
2017
28805820
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
Nat Med
2017
28652380
Immune Escape in Breast Cancer During <i>In Situ</i> to Invasive Carcinoma Transition.
Cancer Discov
2017
26987535
Intratumor Heterogeneity in Breast Cancer.
Adv Exp Med Biol
2016
27923047
Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.
PLoS Med
2016
27626181
LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer.
Oncotarget
2016
27153190
MicroRNA signatures in cytopathology: Are they ready for prime time?
Cancer Cytopathol
2016
25879784
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.
BMC Cancer
2015
23994879
Tactoid body features in a Schwann cell hamartoma of colonic mucosa.
Int J Surg Pathol
2014
25224477
Tumor heterogeneity: the Lernaean hydra of oncology?
Oncology (Williston Park)
2014
25053543
p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
J Clin Pathol
2014
24889678
Metastatic breast cancer: mechanisms and opportunities for cytology.
Cytopathology
2014
24939141
Primary relapse site pattern in women with triple-negative breast cancer.
Pathol Res Pract
2014
24623593
Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL.
Diagn Cytopathol
2014
24478259
Growing indication for FNA to study and analyze tumor heterogeneity at metastatic sites.
Cancer Cytopathol
2014
23112116
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
J Clin Pathol
2013
23907124
Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
Cell Cycle
2013
23773891
Improved malignancy prediction by B3 breast lesions subclassification.
Ann Diagn Pathol
2013
22464812
Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature.
J Crohns Colitis
2012
18394139
Training does not affect exhaled nitric oxide in competitive swimmers.
Allergy
2008
1 - 35 of 35
Column Actions
Search
Recommended Authors
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year
2012
Number of shared co-authors
7
Hans Kristian Moen Vollan
F Hoffmann-La Roche Ltd
Career Start Year
2010
Number of shared co-authors
4
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Career Start Year
2009
Number of shared co-authors
8
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Career Start Year
2009
Number of shared co-authors
8
Charlotte K Y Ng
University of Bern
Career Start Year
2009
Number of shared co-authors
12
Salvatore Piscuoglio
University of Basel
Career Start Year
2008
Number of shared co-authors
10
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year
2007
Number of shared co-authors
2
Samuel Leung
University of British Columbia
Career Start Year
2007
Number of shared co-authors
3
Pamela J Provan
Westmead Institute for Medical Research, Westmead Hospital, The University of Sydney
Career Start Year
2006
Number of shared co-authors
0
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year
2005
Number of shared co-authors
10
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
6
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Career Start Year
2004
Number of shared co-authors
11
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year
2003
Number of shared co-authors
3
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year
2002
Number of shared co-authors
0
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year
2002
Number of shared co-authors
8
Maryou B Lambros
The Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
4
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year
2001
Number of shared co-authors
2
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year
2000
Number of shared co-authors
0
Luciano G Martelotto
Monash University
Career Start Year
2000
Number of shared co-authors
7
Rita A Sakr
Universite Libre de Bruxelles
Career Start Year
2000
Number of shared co-authors
9
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year
1997
Number of shared co-authors
4
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year
1996
Number of shared co-authors
2
Susan J Done
University Health Network
Career Start Year
1994
Number of shared co-authors
0
David G Huntsman
University of British Columbia
Career Start Year
1994
Number of shared co-authors
9
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year
1993
Number of shared co-authors
3
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year
1989
Number of shared co-authors
10
Laura J Van't Veer
University of California San Francisco
Career Start Year
1984
Number of shared co-authors
9
Sunil R Lakhani
University of Queensland
Career Start Year
1983
Number of shared co-authors
7
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year
1981
Number of shared co-authors
2
Jeffrey S Ross
Foundation Medicine
Career Start Year
1974
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers
11
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Co-authored papers
4
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
4
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Vitali Liauchuk
United Institute of Informatics Problems
Co-authored papers
2
Jiaoti Huang
Duke University School of Medicine
Co-authored papers
2
Nasir Rajpoot
University of Warwick, University Hospitals Coventry, UK The Alan Turing Institute
Co-authored papers
2
Babak Ehteshami Bejnordi
Radboud University Medical Center
Co-authored papers
2
Dayong Wang
Harbin Medical University
Co-authored papers
2
Nikolas Stathonikos
University Medical Center Utrecht
Co-authored papers
2
Vassili Kovalev
United Institute of Informatics Problems
Co-authored papers
2
Mitko Veta
Eindhoven University of Technology
Co-authored papers
2
Alex Toker
Co-authored papers
2
Talha Qaiser
University of Warwick
Co-authored papers
2
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
2
Hady Ahmady Phoulady
California State University
Co-authored papers
2
David Tellez
Phoenix Children's Hospital
Co-authored papers
2
Kimmo Kartasalo
Karolinska Institutet
Co-authored papers
1
Peter Bult
Radboud University Medical Center
Co-authored papers
1
Mustafa ??mit ??ner
Middle East Technical University
Co-authored papers
1
Oscar D??niz
University of Castilla-La Mancha
Co-authored papers
1
Yasheng Zhu
Changhai Hospital, Naval Military Medical University
Co-authored papers
1
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers
1
Aoxiao Zhong
Massachusetts General Hospital, Harvard University
Co-authored papers
1
Matt Berseth
NLP Logix LLC
Co-authored papers
1
Muhammad Shaaban
Huazhong Agricultural University
Co-authored papers
1
Rui Ven??ncio
Sorbonne University, Pierre and Marie Curie University
Co-authored papers
1
1 - 30